CA2642340A1 — Metoprolol succinate e.r. tablets and methods for their preparation
Assigned to Teva Pharmaceutical Industries Ltd · Expires 2007-08-30 · 19y expired
What this patent protects
The present invention provides extended release pharmaceutical compositions of a beta blocker such as, but not limited to, metoprolol succinate as the active ingredient and methods of preparing such extended release pharmaceutical compositions.
USPTO Abstract
The present invention provides extended release pharmaceutical compositions of a beta blocker such as, but not limited to, metoprolol succinate as the active ingredient and methods of preparing such extended release pharmaceutical compositions.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.